CG Oncology, Inc. (CGON)
64.55
-0.21
(-0.32%)
USD |
NASDAQ |
May 21, 16:00
64.55
0.00 (0.00%)
After-Hours: 19:59
CG Oncology EPS Diluted (Quarterly) : -0.7123 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Catalyst Pharmaceuticals, Inc. | 0.5022 |
| Gilead Sciences, Inc. | 1.612 |
| Neurocrine Biosciences, Inc. | 1.914 |
| XOMA Royalty Corp. | 0.173 |
| Puma Biotechnology, Inc. | -0.0738 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -60.20M |
| Revenue (Quarterly) | 1.083M |
| Total Expenses (Quarterly) | 61.28M |
| Enterprise Value | 4.282B |
| Gross Profit Margin (Quarterly) | -177.3% |
| Profit Margin (Quarterly) | -5.56K% |
| Earnings Yield | -3.63% |
| Normalized Earnings Yield | -3.629 |